评估全球喘倡议指南更新在商业保险,基于价值的护理人口中的采用情况
Lindsey M McInturff1, Spenser Smith1
1Blue Cross and Blue Shield of North Carolina, Durham.
Journal of managed care & specialty pharmacy
|February 28, 2025
概括
该研究发现,使用吸入性皮质类固醇 (ICSs) -formoterol作为喘缓解剂可使喘恶化减少25.6%. 然而,这种喘治疗导致药房和总成本增加,尽管医疗费用较低.
科学领域:
- 肺部病理学 肺部病理学
- 药物经济学 药物经济学
- 现实世界的证据研究研究.
背景情况:
- 喘是美国普遍存在的慢性呼吸道疾病,造成了巨大的经济成本.
- 更新的"全球喘倡议"指南建议吸入性皮质类固醇 (ICSs) - 形式醇作为首选的喘缓解剂.
- 关于本指南更新的临床和经济影响的现实数据有限.
研究的目的:
- 评估在采用ICSs-formoterol作为首选缓解剂之前和之后的真实世界喘结果和成本.
- 评估更新的喘治疗指南对患者健康和医疗保健支出的影响.
主要方法:
- 一项回顾性,观察性队列研究分析了商业保险成员的索赔数据,年龄为6-65岁,患有喘.
- 这项研究比较了12个月的预期期和12个月的后期,在开始使用ICSs-formoterol吸入器后.
- 主要结局包括每年喘恶化和喘特异性药房,医疗和总成本.
主要成果:
- 年平均喘恶化减少了25.6% (0.347到0.258,P=0.028).
- 平均喘特异性药房费用大幅增加 (474美元至1,796美元,P<0.001).
- 平均喘总费用大幅上 (1505美元至2567美元,P<0.001),而平均医疗费用则下降 (1031美元至771美元,P=0.031).
结论:
- 启动ICS-formoterol用于喘管理与减轻恶化相关,但药房和总成本增加.
- 尽管药费增加,但与喘护理相关的医疗费用下降.
- 卫生计划应考虑促进遵守指导方针的策略,并进一步减少喘恶化.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Asthma: Pathogenesis and Management
324
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
324
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


